National Medical Care Company

SASE:4005 Rapporto sulle azioni

Cap. di mercato: ر.س7.7b

National Medical Care Crescita futura

Future criteri di controllo 2/6

National Medical Care prevede che gli utili e i ricavi cresceranno rispettivamente di 11.1% e 11.7% all'anno. Si prevede che l'EPS crescerà di 11% all'anno. Si prevede che il ritorno sul capitale proprio sarà di 17.8% in 3 anni.

Informazioni chiave

11.1%

Tasso di crescita degli utili

11.0%

Tasso di crescita dell'EPS

Healthcare crescita degli utili14.0%
Tasso di crescita dei ricavi11.7%
Rendimento futuro del capitale proprio17.8%
Copertura analitica

Low

Ultimo aggiornamento08 Jan 2025

Aggiornamenti recenti sulla crescita futura

Analysts Are Updating Their National Medical Care Company (TADAWUL:4005) Estimates After Its Second-Quarter Results

Aug 06
Analysts Are Updating Their National Medical Care Company (TADAWUL:4005) Estimates After Its Second-Quarter Results

Recent updates

National Medical Care (TADAWUL:4005) Might Have The Makings Of A Multi-Bagger

Jan 30
National Medical Care (TADAWUL:4005) Might Have The Makings Of A Multi-Bagger

If EPS Growth Is Important To You, National Medical Care (TADAWUL:4005) Presents An Opportunity

Jan 08
If EPS Growth Is Important To You, National Medical Care (TADAWUL:4005) Presents An Opportunity

What National Medical Care Company's (TADAWUL:4005) P/E Is Not Telling You

Dec 12
What National Medical Care Company's (TADAWUL:4005) P/E Is Not Telling You

National Medical Care's (TADAWUL:4005) Solid Earnings May Rest On Weak Foundations

Oct 29
National Medical Care's (TADAWUL:4005) Solid Earnings May Rest On Weak Foundations

National Medical Care (TADAWUL:4005) Shareholders Will Want The ROCE Trajectory To Continue

Sep 25
National Medical Care (TADAWUL:4005) Shareholders Will Want The ROCE Trajectory To Continue

Analysts Are Updating Their National Medical Care Company (TADAWUL:4005) Estimates After Its Second-Quarter Results

Aug 06
Analysts Are Updating Their National Medical Care Company (TADAWUL:4005) Estimates After Its Second-Quarter Results

Getting In Cheap On National Medical Care Company (TADAWUL:4005) Is Unlikely

Jul 26
Getting In Cheap On National Medical Care Company (TADAWUL:4005) Is Unlikely

National Medical Care Company's (TADAWUL:4005) Shares May Have Run Too Fast Too Soon

Apr 05
National Medical Care Company's (TADAWUL:4005) Shares May Have Run Too Fast Too Soon

We Think National Medical Care's (TADAWUL:4005) Robust Earnings Are Conservative

Mar 14
We Think National Medical Care's (TADAWUL:4005) Robust Earnings Are Conservative

National Medical Care (TADAWUL:4005) Is Very Good At Capital Allocation

Mar 13
National Medical Care (TADAWUL:4005) Is Very Good At Capital Allocation

Some Confidence Is Lacking In National Medical Care Company's (TADAWUL:4005) P/E

Dec 27
Some Confidence Is Lacking In National Medical Care Company's (TADAWUL:4005) P/E

Returns On Capital Are Showing Encouraging Signs At National Medical Care (TADAWUL:4005)

Dec 05
Returns On Capital Are Showing Encouraging Signs At National Medical Care (TADAWUL:4005)

We Like These Underlying Return On Capital Trends At National Medical Care (TADAWUL:4005)

Aug 07
We Like These Underlying Return On Capital Trends At National Medical Care (TADAWUL:4005)

Is National Medical Care Company (TADAWUL:4005) Worth ر.س107 Based On Its Intrinsic Value?

May 29
Is National Medical Care Company (TADAWUL:4005) Worth ر.س107 Based On Its Intrinsic Value?

Investors Will Want National Medical Care's (TADAWUL:4005) Growth In ROCE To Persist

May 08
Investors Will Want National Medical Care's (TADAWUL:4005) Growth In ROCE To Persist

Investors Will Want National Medical Care's (TADAWUL:4005) Growth In ROCE To Persist

Dec 19
Investors Will Want National Medical Care's (TADAWUL:4005) Growth In ROCE To Persist

A Look At The Fair Value Of National Medical Care Company (TADAWUL:4005)

Oct 19
A Look At The Fair Value Of National Medical Care Company (TADAWUL:4005)

National Medical Care (TADAWUL:4005) Is Doing The Right Things To Multiply Its Share Price

Aug 15
National Medical Care (TADAWUL:4005) Is Doing The Right Things To Multiply Its Share Price

National Medical Care's (TADAWUL:4005) Returns On Capital Are Heading Higher

May 13
National Medical Care's (TADAWUL:4005) Returns On Capital Are Heading Higher

Earnings Update: National Medical Care Company (TADAWUL:4005) Just Reported Its Annual Results And Analysts Are Updating Their Forecasts

Mar 03
Earnings Update: National Medical Care Company (TADAWUL:4005) Just Reported Its Annual Results And Analysts Are Updating Their Forecasts

A Look At The Fair Value Of National Medical Care Company (TADAWUL:4005)

Feb 10
A Look At The Fair Value Of National Medical Care Company (TADAWUL:4005)

Returns At National Medical Care (TADAWUL:4005) Appear To Be Weighed Down

Nov 10
Returns At National Medical Care (TADAWUL:4005) Appear To Be Weighed Down

Returns On Capital At National Medical Care (TADAWUL:4005) Have Hit The Brakes

Jul 02
Returns On Capital At National Medical Care (TADAWUL:4005) Have Hit The Brakes

Estimating The Intrinsic Value Of National Medical Care Company (TADAWUL:4005)

Apr 14
Estimating The Intrinsic Value Of National Medical Care Company (TADAWUL:4005)

Is National Medical Care Company (TADAWUL:4005) A Risky Dividend Stock?

Mar 25
Is National Medical Care Company (TADAWUL:4005) A Risky Dividend Stock?

Will National Medical Care (TADAWUL:4005) Multiply In Value Going Forward?

Feb 23
Will National Medical Care (TADAWUL:4005) Multiply In Value Going Forward?

Update: National Medical Care (TADAWUL:4005) Stock Gained 25% In The Last Five Years

Feb 09
Update: National Medical Care (TADAWUL:4005) Stock Gained 25% In The Last Five Years

National Medical Care Company's (TADAWUL:4005) Stock Been Rising But Financials Look Weak: Should Shareholders Be Worried?

Jan 27
National Medical Care Company's (TADAWUL:4005) Stock Been Rising But Financials Look Weak: Should Shareholders Be Worried?

Calculating The Fair Value Of National Medical Care Company (TADAWUL:4005)

Jan 14
Calculating The Fair Value Of National Medical Care Company (TADAWUL:4005)

Is National Medical Care Company's (TADAWUL:4005) 3.8% Dividend Sustainable?

Dec 25
Is National Medical Care Company's (TADAWUL:4005) 3.8% Dividend Sustainable?

Does National Medical Care's (TADAWUL:4005) Statutory Profit Adequately Reflect Its Underlying Profit?

Dec 10
Does National Medical Care's (TADAWUL:4005) Statutory Profit Adequately Reflect Its Underlying Profit?

What Kind Of Shareholders Hold The Majority In National Medical Care Company's (TADAWUL:4005) Shares?

Nov 24
What Kind Of Shareholders Hold The Majority In National Medical Care Company's (TADAWUL:4005) Shares?

Previsioni di crescita degli utili e dei ricavi

SASE:4005 - Stime future degli analisti e dati finanziari passati (SAR Millions )
DataRicaviGuadagniFlusso di cassa liberoLiquidità dell'operazioneAvg. Numero di analisti
12/31/20271,8184003084691
12/31/20261,7333682334094
12/31/20251,5683351333064
12/31/20241,318284-222305
9/30/20241,221274-322-85N/A
6/30/20241,171288-13488N/A
3/31/20241,119266212423N/A
12/31/20231,082241412467N/A
9/30/20231,034233838704N/A
6/30/2023997202670531N/A
3/31/2023968196349386N/A
12/31/2022918170185217N/A
9/30/2022882151-16252N/A
6/30/2022857142-12686N/A
3/31/2022843131845N/A
12/31/20218451365694N/A
9/30/20218441225894N/A
6/30/20218451051549N/A
3/31/20218281001740N/A
12/31/20208099788107N/A
9/30/202078095187198N/A
6/30/202074095216225N/A
3/31/202072483155162N/A
12/31/201970880152162N/A
9/30/201970565236246N/A
6/30/201970760245259N/A
3/31/201973767188206N/A
12/31/201876462299318N/A
9/30/201881081199231N/A
6/30/201884296N/A236N/A
3/31/201885995N/A279N/A
12/31/201785585N/A113N/A
9/30/2017817-8N/A-9N/A
6/30/2017806-7N/A70N/A
3/31/201784933N/A72N/A
12/31/201690150N/A103N/A
9/30/2016931155N/A87N/A
6/30/2016945153N/A63N/A
3/31/2016913136N/A77N/A
12/31/2015879131N/A51N/A
9/30/2015853106N/A127N/A
6/30/2015820102N/A80N/A
3/31/201577291N/A38N/A
12/31/201473495N/A71N/A
9/30/2014703106N/A32N/A
6/30/2014660103N/A15N/A
3/31/201462394N/A75N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: La crescita prevista degli utili di 4005 ( 11.1% all'anno) è inferiore al tasso di risparmio ( 14.9% ).

Guadagni vs Mercato: Si prevede che gli utili di 4005 ( 11.1% all'anno) cresceranno più rapidamente del mercato SA ( 5.8% all'anno).

Guadagni ad alta crescita: Si prevede che gli utili di 4005 cresceranno, ma non in modo significativo.

Ricavi vs Mercato: Si prevede che il fatturato di 4005 ( 11.7% all'anno) crescerà più rapidamente del mercato SA ( -0.6% all'anno).

Ricavi ad alta crescita: Si prevede che il fatturato di 4005 ( 11.7% all'anno) crescerà più lentamente di 20% all'anno.

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

ROE futuro: Si prevede che il Return on Equity di 4005 sarà basso tra 3 anni ( 17.8 %).

Scoprire le aziende in crescita

7D

1Y

7D

1Y

7D

1Y

Analisi aziendale e situazione dei dati finanziari

DatiUltimo aggiornamento (ora UTC)
Analisi dell'azienda2025/02/22 05:02
Prezzo dell'azione a fine giornata2025/02/20 00:00
Guadagni2024/09/30
Guadagni annuali2023/12/31

Fonti dei dati

I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.

PacchettoDatiTempisticaEsempio Fonte USA *
Dati finanziari della società10 anni
  • Conto economico
  • Rendiconto finanziario
  • Bilancio
Stime di consenso degli analisti+3 anni
  • Previsioni finanziarie
  • Obiettivi di prezzo degli analisti
Prezzi di mercato30 anni
  • Prezzi delle azioni
  • Dividendi, scissioni e azioni
Proprietà10 anni
  • Top azionisti
  • Insider trading
Gestione10 anni
  • Team di leadership
  • Consiglio di amministrazione
Sviluppi principali10 anni
  • Annunci aziendali

* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.

Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.

Modello di analisi e Snowflake

I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina Github; abbiamo anche guide su come utilizzare i nostri report e tutorial su Youtube.

Scoprite il team di livello mondiale che ha progettato e realizzato il modello di analisi Simply Wall St.

Metriche di settore e industriali

Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.

Fonti analitiche

National Medical Care Company è coperta da 11 analisti. 4 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.

AnalistaIstituzione
Ibrahim ElaiwatAljazira Capital Company
Jassim Al-JubranAljazira Capital Company
Madhu AppissaAl Rajhi Capital